Hürthle cell neoplasms of the thyroid.
The approach to Hürthle cell neoplasms of the thyroid gland remains controversial because there is no consensus on the criteria used to establish malignancy. Invasion into the thyroid capsule, blood vessels, and contiguous structures in the neck and lymph nodes, or distant metastases establishes malignancy. Benign Hürthle cell lesions should be treated with total lobectomy and isthmusectomy. Total thyroidectomy is the recommended treatment for malignant Hürthle cell lesions.
Department of Surgery, University of Michigan Medical Center, Ann Arbor.
M K
MK
McLeod
N W
NW
Thompson
D000367:Age Factors; D000368:Aged; D002277:Carcinoma / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D002471:Cell Transformation, Neoplastic / Q000473:pathology; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000532:radiotherapy / Q000556:secondary; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011182:Postoperative Care; D011877:Radionuclide Imaging; D011879:Radiotherapy Dosage; D012737:Sex Factors; D013961:Thyroid Gland / Q000473:pathology* / Q000601:surgery; D013964:Thyroid Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D013965:Thyroidectomy / Q000379:methods*
D007457:Iodine Radioisotopes